RPL13AP20

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RPL13AP20 mutation is significantly associated with the RNA expression of many other genes, with 80 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible RPL13AP20-associated genes across cancer lineages are RPL23AP86, SNRPCP20, and NFILZ. Each is linked with RPL13AP20 in more than 1 cancer types. Because this analysis shows association rather than direction, both RPL13AP20-to-partner and partner-to-RPL13AP20 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RPL23AP86 grouped by RPL13AP20-low versus RPL13AP20-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL13AP20→partner) and Y-score (partner→RPL13AP20) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECRPL23AP86 →+0.260+3.738.003.00631
UCECSNRPCP20 →+0.427+3.463<.001.00331
UCECNFILZ →+0.337+3.041.003.00831
UCECNUTF2P8 →+0.196+3.567<.001.00531
UCECRPL23AP90 →+0.459+3.741.003.00631
UCECMIR98 →+0.509+3.386<.001.00831
Each partner links to its Q-omics profile. Showing the 6 strongest of 80 associations by consensus.

RPL23AP86 by RPL13AP20 expression — UCEC

Box plot of RPL23AP86 in RPL13AP20-low vs RPL13AP20-high samples in UCEC.

Explore this box plot interactively →

Exploration